{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:25:04Z","timestamp":1749320704524},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00417-021-05270-5","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T02:02:42Z","timestamp":1623981762000},"page":"3295-3303","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using optical coherence tomography angiography to guide myopic choroidal neovascularization treatment: a 3-year follow-up study"],"prefix":"10.1007","volume":"259","author":[{"given":"Tomoko","family":"Ueda-Consolvo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Oiwake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"5270_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K et al (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1297\u20131305. https:\/\/doi.org\/10.1016\/S0161-6420(03)00461-5","journal-title":"Ophthalmology"},{"key":"5270_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","volume":"121","author":"S Wolf","year":"2014","unstructured":"Wolf S, Balciuniene VJ, Laganovska G et al (2014) RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121:682-692.e682. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.023","journal-title":"Ophthalmology"},{"key":"5270_CR3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","volume":"122","author":"Y Ikuno","year":"2015","unstructured":"Ikuno Y, Ohno-Matsui K, Wong TY et al (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR Study. Ophthalmology 122:1220\u20131227. https:\/\/doi.org\/10.1016\/j.ophtha.2015.01.025","journal-title":"Ophthalmology"},{"key":"5270_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00417-015-3076-1","volume":"254","author":"V Sarao","year":"2016","unstructured":"Sarao V, Veritti D, Macor S, Lanzetta P (2016) Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes. Graefes Arch Clin Exp Ophthalmol 254:445\u2013454. https:\/\/doi.org\/10.1007\/s00417-015-3076-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5270_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000333213","volume":"227","author":"N Franqueira","year":"2012","unstructured":"Franqueira N, Cachulo ML, Pires I et al (2012) Long-term follow-up of myopic choroidal neovascularization treated with ranibizumab. Ophthalmologica 227:39\u201344. https:\/\/doi.org\/10.1159\/000333213","journal-title":"Ophthalmologica"},{"key":"5270_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/IAE.0000000000001313","volume":"37","author":"K Kasahara","year":"2017","unstructured":"Kasahara K, Moriyama M, Morohoshi K et al (2017) Six-year outcomes of intravitreal bevacizumab for choroidal neovascularization in patients with pathologic myopia. Retina 37:1055\u20131064. https:\/\/doi.org\/10.1097\/IAE.0000000000001313","journal-title":"Retina"},{"key":"5270_CR7","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/IAE.0000000000000632","volume":"35","author":"JM Ruiz-Moreno","year":"2015","unstructured":"Ruiz-Moreno JM, Montero JA, Araiz J et al (2015) Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia: six years outcome. Retina 35:2450\u20132456. https:\/\/doi.org\/10.1097\/IAE.0000000000000632","journal-title":"Retina"},{"key":"5270_CR8","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/IAE.0000000000001384","volume":"37","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee SC, Kim SH et al (2017) Choroidal thickness and chorioretinal atrophy in myopic choroidal neovascularization with anti-vascular endothelial growth factor therapy. Retina 37:1516\u20131522. https:\/\/doi.org\/10.1097\/IAE.0000000000001384","journal-title":"Retina"},{"key":"5270_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00417-003-0803-9","volume":"242","author":"A Kojima","year":"2004","unstructured":"Kojima A, Ohno-Matsui K, Teramukai S et al (2004) Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 242:114\u2013119. https:\/\/doi.org\/10.1007\/s00417-003-0803-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5270_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/IAE.0b013e3182278bae","volume":"32","author":"K Hayashi","year":"2012","unstructured":"Hayashi K, Shimada N, Moriyama M et al (2012) Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization in Japanese patients with pathologic myopia. Retina 32:687\u2013695. https:\/\/doi.org\/10.1097\/IAE.0b013e3182278bae","journal-title":"Retina"},{"key":"5270_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1159\/000442800","volume":"101","author":"G Querques","year":"2017","unstructured":"Querques G, Giuffr\u00e8 C, Corvi F et al (2017) Optical coherence tomography angiography of myopic choroidal neovascularization. Br J Ophthalmol 101:609\u2013615. https:\/\/doi.org\/10.1159\/000442800","journal-title":"Br J Ophthalmol"},{"key":"5270_CR12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1097\/IAE.0000000000000836","volume":"35","author":"NW Muakkassa","year":"2015","unstructured":"Muakkassa NW, Chin AT, de Carlo TE et al (2015) Characterizing the effect of anti-vascular endothelial growth factor therapy on treatment-na\u00efve choroidal neovascularization using optical coherence tomography angiography. Retina 35:2252\u20132259. https:\/\/doi.org\/10.1097\/IAE.0000000000000836","journal-title":"Retina"},{"key":"5270_CR13","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1097\/IAE.0000000000000879","volume":"35","author":"B Lumbroso","year":"2015","unstructured":"Lumbroso B, Rispoli M, Savastano MC (2015) Longitudinal optical coherence tomography-angiography study of type 2 na\u00efve choroidal neovascularization early response after treatment. Retina 35:2242\u20132251. https:\/\/doi.org\/10.1097\/IAE.0000000000000879","journal-title":"Retina"},{"key":"5270_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/IAE.0000000000002005","volume":"39","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Li Y, Huang X, Qu Y (2019) Application of optical coherence tomography angiography to assess anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization. Retina 39:712\u2013718. https:\/\/doi.org\/10.1097\/IAE.0000000000002005","journal-title":"Retina"},{"key":"5270_CR15","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/IAE.0000000000000610","volume":"35","author":"DS Ng","year":"2015","unstructured":"Ng DS, Kwok AK, Tong JM et al (2015) Factors influencing need for retreatment and long-term visual outcome after intravitreal bevacizumab for myopic choroidal neovascularization. Retina 35:2457\u20132468. https:\/\/doi.org\/10.1097\/IAE.0000000000000610","journal-title":"Retina"},{"key":"5270_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00175988","volume":"232","author":"AG Bennett","year":"1994","unstructured":"Bennett AG, Rudnicka AR (1994) Edgar DF (1994) Improvements on Littmann\u2019s method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol 232:361\u2013367. https:\/\/doi.org\/10.1007\/BF00175988","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5270_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/IAE.0000000000001576","volume":"37","author":"Y Ichiyama","year":"2017","unstructured":"Ichiyama Y, Sawada T, Ito Y et al (2017) Optical coherence tomography angiography reveals blood flow in choroidal neovascular membrane in remission phase of neovascular age-related macular degeneration. Retina 37:724\u2013730. https:\/\/doi.org\/10.1097\/IAE.0000000000001576","journal-title":"Retina"},{"key":"5270_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Ohtsu","year":"1979","unstructured":"Ohtsu N (1979) A threshold selection method from gray level histograms. IEEE Trans Sys Man Cyber 9:62\u201366. https:\/\/doi.org\/10.1109\/TSMC.1979.4310076","journal-title":"IEEE Trans Sys Man Cyber"},{"key":"5270_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG et al (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of atrophy report 3. Ophthalmology 125:537\u2013548. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.028","journal-title":"Ophthalmology"},{"key":"5270_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ophtha.2019.09.030","volume":"127","author":"S Gune","year":"2020","unstructured":"Gune S, Abdelfattah NS, Karamat A et al (2020) Spectral-domain OCT-based prevalence and progression of macular atrophy in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 127:523\u2013532. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.030","journal-title":"Ophthalmology"},{"key":"5270_CR21","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1167\/iovs.12-11542","volume":"54","author":"SJ Ahn","year":"2013","unstructured":"Ahn SJ, Woo SJ, Kim KE et al (2013) Association between choroidal morphology and anti-vascular endothelial growth factor treatment outcome in myopic choroidal neovascularization. Invest Ophthalmol Vis Sci 54:2115\u20132122. https:\/\/doi.org\/10.1167\/iovs.12-11542","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5270_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00417-018-04214-w","volume":"257","author":"K Sayanagi","year":"2019","unstructured":"Sayanagi K, Hara C, Wakabayashi T et al (2019) Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 257:749\u2013757. https:\/\/doi.org\/10.1007\/s00417-018-04214-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5270_CR23","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1167\/iovs.14-14610","volume":"55","author":"M Hata","year":"2014","unstructured":"Hata M, Oishi A, Tsujikawa A et al (2014) Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability. Invest Ophthalmol Vis Sci 55:7874\u20137880. https:\/\/doi.org\/10.1167\/iovs.14-14610","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5270_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IAE.0b013e3182657fff","volume":"33","author":"N Lois","year":"2013","unstructured":"Lois N, McBain V, Abdelkader E et al (2013) Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy. Retina 33:13\u201322. https:\/\/doi.org\/10.1097\/IAE.0b013e3182657fff","journal-title":"Retina"},{"key":"5270_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","volume":"121","author":"JE Grunwald","year":"2014","unstructured":"Grunwald JE, Daniel E, Huang J et al (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121:150\u2013161. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.015","journal-title":"Ophthalmology"},{"key":"5270_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2015.09.032","volume":"161","author":"Y Kuroda","year":"2016","unstructured":"Kuroda Y, Yamashiro K, Tsujikawa A et al (2016) Retinal pigment epithelial atrophy in neovascular age-related macular degeneration after ranibizumab treatment. Am J Ophthalmol 161:94-103.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.09.032","journal-title":"Am J Ophthalmol"},{"key":"5270_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ajo.2014.10.035","volume":"159","author":"HJ Cho","year":"2015","unstructured":"Cho HJ, Yoo SG, Kim HS et al (2015) Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol 159:285-292.e1. https:\/\/doi.org\/10.1016\/j.ajo.2014.10.035","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05270-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05270-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05270-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T06:25:59Z","timestamp":1634538359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05270-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5270"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05270-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of the Institutional Review Board of the University of Toyama and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}